Delivery Order SPE2DR25D2101-SPE2DR26F46RN
- Not listed
- The Defense Logistics Agency awarded a $15,164.14 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Hyzaar 50-12.5 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $7,941.41 delivery order to AmerisourceBergen Drug Corp for HYZAAR 100-12.5 tablets (90-count units) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply requirement supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (a combination antihypertensive medication) in the quantity of 30 units, with a ceiling value of $1,059.30. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is classified as a child award, indicating it derives from a larger contract vehicle. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,464.33 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (90-count units) under a firm fixed price contract. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine...
- The Defense Logistics Agency awarded a $2,889.30 delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablet medication (30-count supply), with an ultimate completion date of July 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving the federal medical procurement sector, particularly supporting military and veteran...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $18,492.07 award is for the supply of Hyzaar 100-25 tablets, a brand name pharmaceutical product. AmerisourceBergen Drug Corporation holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,505.77, is for the delivery of HYZAAR 100-25 TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of December 19, 2023 and is a firm-fixed-price delivery order. Amerisourcebergen is not a small business, and this contract does not have a set-aside...
- This is a $1,592.43 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYZAAR 50-12.5 TABLET 90S, a medication, to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,973.76 contract is for the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, to be delivered by January 30, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $2,032.02. The order is for 4562654971 HYZAAR 100-25 TABLET 30S to be delivered by November 1, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract between Amerisourcebergen and DLA Troop...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46RNDelivery Order
The Defense Logistics Agency awarded a $1,474.23 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Hyzaar 100-25, a combination antihypertensive medication used to treat high blood pressure. This firm fixed-price delivery order, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, was competitively awarded without a set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs and federal medical procurement needs. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant portfolio of federal contracts across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet critical medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/17/25 |